Pazdur warns that politics, ‘chaos’ are damaging FDA
statnews.com • • business
Key Points:
- Richard Pazdur, a former FDA regulator, stated that the separation between political appointees and drug reviewers at the FDA has been compromised.
- He criticized the lack of transparency in a new voucher program that allows accelerated review for certain drugs chosen by Trump administration officials.
- Pazdur highlighted that meetings about drugs in the voucher program are held in a small conference room near the commissioner’s office, limiting attendance and excluding much of the review staff.
- He expressed concern that most participants in these meetings report directly to FDA Commissioner Marty Makary, which he views as problematic.
